Considering the potential size of the litigation, consolidated proceedings like the one established in New Jersey state court and the recent MDL will provide an efficient means of resolving Stryker hip lawsuits.
New York, New York (PRWEB) June 13, 2013
Stryker hip lawsuit claims filed in the wake of the July 2012 Rejuvenate and ABG II Modular-Neck Hip Stem recall have been consolidated in a multidistrict litigation and transferred to the U.S. District Court, District of Minnesota for pretrial proceedings, Bernstein Liebhard LLP reports. A Transfer Order issued by the U.S. Judicial Panel on Multidistrict Litigation (JPML) on June 12, 2013 encompasses 41 Stryker hip replacement lawsuits initially filed in 16 federal jurisdictions. The Panel noted that it was aware that an additional 110 potentially-related Stryker hip recall claims are also pending in various federal district courts. According to the Transfer Order, U.S. District Judge Donavan W. Frank has been tapped to preside over the Stryker litigation in Minnesota. (In re: Stryker Rejuvenate and ABG II Hip Implant Products Liability Litigation, MDL No. 2441)
“Stryker has acknowledged that some 20,000 Rejuvenate and ABG II hip stems were sold prior to the announcement of the Stryker hip recall. Considering the potential size of the litigation, consolidated proceedings like the one established in New Jersey state court and the recent MDL will provide an efficient means of resolving Stryker hip lawsuits,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is representing clients in Stryker hip replacement lawsuits, and continues to offer free legal evaluations to individuals who have allegedly suffered serious complications associated with the Stryker hip recall for Rejuvenate and ABG II Modular-Neck Hip Stems.
Stryker Hip Lawsuits
The Stryker hip recall was announced in July 2012, after post-market surveillance data indicated the Rejuvenate and ABG II hip stems were likely to suffer from fretting and corrosion at the modular neck junction. According to Stryker’s recall notice, recipients of these hip components may be at risk for pain, swelling and adverse local tissue reactions, as well as the need to have the hip replaced. Stryker has advised all affected patients, even those who have not experienced any symptoms associated with a failing hip, to undergo blood tests for elevated metal ion levels and cross sectional imaging to ensure their Rejuvenate and ABG II stems are functioning properly.*
In January, the New Jersey Supreme Court ordered the transfer of all Stryker hip replacement lawsuits involving Rejuvenate and ABG II components filed in that state to Bergen County Superior Court for coordinated case management. Court documents indicate that 161 Stryker hip recall claims are now pending in the New Jersey litigation. In April, Bergen County Superior Court Judge Brian R. Marinetti set forth procedures for the parties to begin selecting cases for early mediation. However, his order stipulated that the case against Stryker will continue while mediation takes place. Bernstein Liebhard LLP is actively filing Stryker hip lawsuits in this proceeding. (In re Stryker Rejuvenate Hip Stem and the ABG II Modular Hip Stem Litigation, No. 296)
Consolidated proceedings like those established for Stryker hip replacement lawsuits are intended for multiple, complex cases that share common allegations of fact. The aim of such a proceeding is to eliminate duplicative discovery, prevent inconsistent pretrial rulings, and conserve the resources of the parties, their counsel and the court.
Individuals allegedly affected by the Stryker hip recall for Rejuvenate and ABG II hip stems may be entitled to compensation for medical bills, lost wages, and pain and suffering. Further information regarding Stryker hip lawsuits is available at Bernstein Liebhard LLP’s website. To learn more, please call 800-511-5092.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP